The first Ebola patient diagnosed in the United States died Wednesday morning in a Dallas hospital, according to a hospital spokesman. Thomas Eric Duncan was pronounced dead at 7:51 a.m. at Texas Health Presbyterian Hospital Dallas, where he was admitted Sept….
Experimental Drug Provided to Dallas Ebola Patient
A North Carolina drugmaker is providing its experimental antiviral drug to a Dallas patient being treated for Ebola, an emergency step authorized by the Food and Drug Administration. Officials at Texas Health Presbyterian Hospital said Monday that their patient, Thomas Eric…
Liberia to Prosecute Man Who Brought Ebola to U.S.
Liberia plans to prosecute the airline passenger who brought Ebola into the U.S., alleging that he lied on an airport questionnaire about not having any contact tracing with an infected person, authorities said Thursday. Thomas Eric Duncan filled out a series…
10 Questions, Answers About the U.S. Ebola Case
U.S. health officials have warned for months that someone infected with Ebola could unknowingly carry the virus to this country, and there is word now that it has happened: A traveler in a Dallas hospital became the first patient diagnosed in…
1000s of Ebola Vaccine Doses in Coming Months
Thousands of doses of experimental Ebola vaccines should be available in the coming months and could eventually be given to health care workers and other people at high risk of the deadly disease, according to the World Health Organization. No vaccine…
1st Volunteer Gets Experimental Ebola Vaccine
British scientists say a former nurse has become the first person in the country to receive an experimental Ebola vaccine in an early trial to test its safety. Ruth Atkins, 48, got the injection on Wednesday in Oxford, the first of…
Two Anti-Ebola Vaccines in Historic Race
One of the most rapidly fast-tracked vaccines in history—an anti-Ebola “ChAd3” vaccine—just entered clinical trial in humans. It may wrap in November. It protected macaques for five weeks, leaping to 10 months when followed by a booster two months later. It…
The Search for Ebola Response Targets
The effort to develop therapeutics and a vaccine against the deadly Ebola virus disease (EVD) requires a complex understanding of the microorganism and its relationship with the host, especially the immune response. Adding to the challenge, EVD can be caused by…
J&J accelerate Ebola Vaccine Development
Johnson & Johnson announced it will fast-track the development of a promising new combination vaccine regimen against Ebola and broadly collaborate with its partners in global health to deliver immediate relief aid to address the current Ebola outbreak. The accelerated vaccine…
Animal to Human Transmission Responsible for 2014 Ebola Outbreak
Scientists used advanced genomic sequencing technology to identify a single point of infection from an animal reservoir to a human in the current Ebola outbreak in West Africa. This research has also revealed the dynamics of how the Ebola virus has…